feed,title,long_url,short_url
Benzinga,Aptinyx Shares Plummet As Mid-Stage Fibromyalgia Study Missed Primary Endpoint,https://benzinga.com/general/biotech/22/08/28475152/aptinyx-shares-plummet-as-mid-stage-fibromyalgia-study-missed-primary-endpoint,https://bit.ly/3SLbB5F
